Biote (BTMD) Liabilities and Shareholders Equity (2020 - 2026)

Biote (BTMD) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $89.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 27.84% year-over-year to $89.0 million; the TTM figure through Mar 2026 stood at $412.8 million (down 6.17% YoY), while the FY2025 annual figure was $107.6 million, down 12.06% from the prior year.
• Liabilities and Shareholders Equity came in at $89.0 million for Q1 2026 at Biote, down from $107.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $317.9 million in Q1 2022, with the low at $89.0 million in Q1 2026.
• Average Liabilities and Shareholders Equity over 5 years is $131.2 million, with a median of $115.3 million recorded in 2022.
• The largest YoY upside for Liabilities and Shareholders Equity was 105.49% in 2022 against a maximum downside of 65.57% in 2022.
• Year by year, Liabilities and Shareholders Equity stood at $111.6 million in 2022, then soared by 39.1% to $155.3 million in 2023, then declined by 21.2% to $122.4 million in 2024, then fell by 12.06% to $107.6 million in 2025, then dropped by 17.27% to $89.0 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $89.0 million, $107.6 million, and $111.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.